1. Home
  2. QUIK vs HUMA Comparison

QUIK vs HUMA Comparison

Compare QUIK & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$10.80

Market Cap

139.5M

Sector

Technology

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.61

Market Cap

134.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUIK
HUMA
Founded
1988
2004
Country
United States
United States
Employees
N/A
184
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.5M
134.7M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
QUIK
HUMA
Price
$10.80
$0.61
Analyst Decision
Buy
Strong Buy
Analyst Count
1
8
Target Price
$11.00
$6.19
AVG Volume (30 Days)
186.6K
9.7M
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,112,000.00
N/A
Revenue This Year
$75.17
$526.55
Revenue Next Year
$16.04
$202.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.34
$0.55
52 Week High
$10.37
$2.93

Technical Indicators

Market Signals
Indicator
QUIK
HUMA
Relative Strength Index (RSI) 70.87 34.85
Support Level $5.96 $0.55
Resistance Level N/A $1.27
Average True Range (ATR) 0.60 0.09
MACD 0.05 -0.01
Stochastic Oscillator 97.98 21.10

Price Performance

Historical Comparison
QUIK
HUMA

About QUIK QuickLogic Corporation

QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: